Skip to content

Clinical observation of qizhufeixian Decoction in the treatment of idiopathic pulmonary interstitial fibrosis

Clinical observation of qizhufeixian Decoction in the treatment of idiopathic pulmonary interstitial fibrosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005853
Enrollment
Unknown
Registered
2022-04-13
Start date
2017-04-09
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic pulmonary fibrosis

Interventions

control group:N acetylcysteine
Treatment group:Bailing Capsule
control group:Bailing Capsule
Treatment group:Qizhu Feixian Decoction
Treatment group:N acetylcysteine

Sponsors

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with non acute episode IPF diagnosed by western medicine; (2) TCM syndrome belongs to Qi deficiency and blood stasis syndrome; (3) Patients with fixed contact information and possibility of follow-up; (4) Aged between 40 and 75.

Exclusion criteria

Exclusion criteria: (1)Those who do not meet the diagnostic and inclusion criteria; (2) Patients with other serious cardiopulmonary diseases, endocrine diseases, autoimmune diseases or chronic consumptive diseases, bronchiectasis, pleural lesions and other diseases; (3) Patients with severe primary diseases such as liver, kidney and hematopoietic system and psychosis; (4) Pregnant and lactating women; (5) Those who fail to take medicine according to the regulations, unable to determine the curative effect or incomplete data affect the determination of curative effec

Design outcomes

Primary

MeasureTime frame
SGRQ;pulmonary function tests;HRCT;kl-6;TCM symptom score;

Countries

China

Contacts

Public ContactLiu Shigang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences,

gamlsg@163.com010-88001444

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026